• Team
  • Services
  • Clients
  • Case Studies
  • News & Events
  • Careers
  • Contact
LaVoie Group has assembled a team of seasoned professionals with extensive experience in marketing, business strategy, corporate communications, as well as public and investor relations covering the life sciences and healthcare sectors.LaVoie Group: News & Events Agency News

LaVoie Group honored by LACP with two awards

LaVoie Group adds Invida to Client Roster

Lindsay Treadway joins the LaVoie Team

LaVoie Group wins 2009 MarCom Gold Award for Rockwell Medical Homepage Design

LaVoie Group adds Spherix Incorporated to Client Roster

Liz Pingpank joins the LaVoie Team

LaVoie Group VP Cloft to Serve on Board of NIRI Boston

LaVoie Group Adds Cardioxyl to Its Client Roster

LaVoie Group Wins Bell Ringer Award from the Publicity Club of New England

LaVoie Group Appointed by Mithridion as PR Agency

LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record

LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster

Featured Coverage

Sanof-Aventis Partenering Event Featured in The Boston Globe

The Wall Street Journal Health Blog discusses Sanofi-Aventis partnerships

Sanofi-Aventis Partnering Event Covered in XConomy

ESBATech lands a new home with Alcon 9.15.2009

Cardioxyl profiled in July 14, 2009 issue of BioWorld Today

EyeGate Pharma featured in Financial Times/Mergermarket article

"Blog for Brand," by Donna LaVoie published in the February 2009 issue of Women's Business

Interleukin Genetics, Neotropix and LaVoie Group featured in the 2009 "Year in Preview" issue of PharmaVOICE

"Micromanaging Oncolytic Viruses," featuring Neotropix in the Nov. 20, 2008 issue of SciBx

Donna LaVoie featured in the Fall 2008 issue of MBC News

"Agile's Low-Dose Birth Control Patch Heads for Phase III," in the Sept. 29, 2008 issue of The Pink Sheets Daily

ESBATech, EyeGate and Ophthotech featured in "The Eyes Have It" in the Sept. 29, 2008 issue of BioCentury

"EyeGate in Phase II study of Ocular Drug Delivery Device," in the July 21, 2008 issue of Medical Device Daily

Lewis Bender, CEO of Interleukin Genetics, featured on NECN's Business Day


Newsletters
Join our Mailing List to receive our newsletter which contains news and information that is relevant to your business.

Winter 2009 - Love Your PR Agency

Holiday 2008 - Beyond Press Releases: Relationships Provide the Competitive Advantage

Fall 2008 - Agency Update: LaVoie Group Adds PR Pro, Carol Zepp as Account Supervisor/Director of Editorial

Fall 2008 - Digital Strategies for Building Awareness for your Corporate and Product Brand

Summer 2008 - Agency Update: LaVoie Group Adds to its Life Science Communications Team

Spring 2008 - Agency Update: LaVoie Group Adds Silence Therapeutics and Interleukin Genetics to its Life Science Agency Roster

Winter 2007 - Strategy and Planning Workshop/2008 Life Sciences Events Planning Calendar Launched

Summer/Early Fall 2007 - Getting Ready for that Important News Event

Fall 2006 - Considering a Foreign Listing?

Winter 2005/2006 - Post-Exit Strategies part 2 of 2

Fall 2005 - 5 Steps To Prepare for a VC Exit part 1 of 2


Events
LaVoie Group will be attending the JP Morgan Healthcare Conference, taking place from January 11-14, 2010 in San Francisco, CA.

To schedule a meeting with us, please contact Donna LaVoie, President and CEO
at 978.745.4200 or info@lavoiegroup.com.